Last updated on September 2017

A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Psoriasis and Psoriatic Disorders
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

  • 18-75 years old
  • Diagnosed for atleast 6 months
  • body surface area at least 10% covered with psoriasis

  • Recruitment Status: Open


    Brief Description Eligibility Contact Research Team


    Receive Emails About New Clinical Trials!

    Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.